Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment (Q36080601)

12 August 2017

1 reference

title

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment (English)

1 reference

12 August 2017

1 reference

1 reference

1 reference

4

Dennis Revicki

1 reference

12 August 2017

6

Fasiha Kanwal

1 reference

12 August 2017

1

Brennan M R Spiegel

1 reference

12 August 2017

Zobair M Younossi

2

1 reference

12 August 2017

Ron D Hays

series ordinal

3

1 reference

12 August 2017

Sean Robbins

series ordinal

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

41

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

790-800

1 reference

Burden of liver disease in the United States: summary of a workshop

12 August 2017

cites work

1 reference

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

7 January 2021

Health-State Utilities and Quality of Life in Hepatitis C Patients

1 reference

7 January 2021

Quality of life and cognitive function in hepatitis C at different stages of liver disease

1 reference

7 January 2021

National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C

1 reference

7 January 2021

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

1 reference

7 January 2021

Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

1 reference

7 January 2021

Subclinical impairment of brain function in chronic hepatitis C infection

1 reference

7 January 2021

Australian women's experiences of living with hepatitis C virus: results from a cross-sectional survey

1 reference

7 January 2021

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

7 January 2021

A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C

1 reference

7 January 2021

1 reference

7 January 2021

1 reference

7 January 2021

1 reference

7 January 2021

Impaired health-related quality of life in Romanian patients with chronic viral hepatitis before antiviral therapy

1 reference

7 January 2021

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life

1 reference

7 January 2021

Quality of life in HCV-infection: lack of association with ALT levels.

1 reference

7 January 2021

Methods to explain the clinical significance of health status measures

1 reference

7 January 2021

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

7 January 2021

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

7 January 2021

Consensus methods: characteristics and guidelines for use

1 reference

7 January 2021

Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis

1 reference

7 January 2021

Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

1 reference

7 January 2021

The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

1 reference

7 January 2021

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

1 reference

7 January 2021

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group

1 reference

7 January 2021

Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.

1 reference

7 January 2021

1 reference

7 January 2021

Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection

1 reference

7 January 2021

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

1 reference

7 January 2021

Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

1 reference

7 January 2021

Emotional distress in chronic hepatitis C patients not receiving antiviral therapy.

1 reference

7 January 2021

"They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C.

1 reference

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

7 January 2021

Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders

1 reference

7 January 2021

The impact of irritable bowel syndrome on health-related quality of life

1 reference

7 January 2021

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

1 reference

7 January 2021

Half standard deviation estimate of the minimally important difference in HRQOL scores?

1 reference

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20659

1 reference

12 August 2017

1 reference